MutualFundWire.com
   The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
Monday, November 9, 2015 Healey Does Three Deals As AMG Beats Estimates Sean Healey and his team keep on racking up the deals, and their earnings are on the rise, too.
Bloomberg, the Financial Times, and Reuters all covered the Systematica deal. And this morning AMG reported economic earnings per share of $2.93 for Q3 2015, up from $2.76 in Q3 2014 and surpassing estimates by $0.06. Yet even as AMG's earnings rose and beat expectations, its revenue did the opposite; for Q3 2015, AMG brought in $613.1 million in revenue, down from $640.3 million a year ago and missing estimates by $22.71 million. Systematica, which AMG describes as "an innovative technology-driven firm focused on the rigorous application of science and technology to the investment process" that is a "managed futures and systematic trading" shop, is the biggest of the three new AMG affiliates-to-be with $8.8 billion in AUM as of October 1. It is led by Leda Braga, and AMG is buying a majority of the Systematica stake held by BlueCrest Capital Management. Systematica has offices in Geneva, Jersey (England), London, New York, and Singapore, and spun out of Blue Crest this past January. Cape Town, South Africa-based Abax (called Polaris Capital until 2009) had $5.4 billion in AUM as of September 30. It's a fundamentals-focused shop that invests in South African stocks and bonds, as well as global equities. The 12-year-old shop is led by senior partners Steve Minnaar, Anthony Sedgwick, Omri Thomas, and Marius van Rooyen. 17-year-old Ivory has offices in LA and New York. As of September 30 it had about $3.6 billion in AUM, and like Abax it is fundamentals-focused. Ivory offers long-short equity and long-only strategies. Printed from: MFWire.com/story.asp?s=52927 Copyright 2015, InvestmentWires, Inc. All Rights Reserved |